Apartment building, Hlavná 35-41 in Orlská 1 Trnava, Slovak Republic
Picture: © Tomas Manina eye one s.r.o./eye two s.r.

The apartment building is a five-section sectional with 6 above-ground floors, basement. It consists of one building system and is free-standing, integrated into the development of multifunctional buildings in the central urban zone of the city of Trnava. The project was developed in 2018; implementation took place in the summer of 2020.

In its original state, the building fully complemented the terraced buildings in the central city zone of Trnava with its architectural design. When designing the renovation, care was taken to preserve the architecture in terms of the physical appearance of the building, as well as the color and structure of the surface treatment of the facade. ETICS renovation of the entire façade area (app. 6,200 m2) played a key role. Together with complementing measures the energy efficiency of the building could remarkably be improves by 43% – from primary energy demand 97.57 kWh/m2/year (class B) to 55.14 kWh/m2/year (class A1). Furthermore, the refurbishment helped extending the lifespan of the existing building stock and increasing the standard of living or use of the premises of the building.

Architect: V-Projekt s.r.o., Ing. Marek Vilček, www.vprojekt.sk
Project owner: n. a.
Installer: Arcus Signum, s.r.o., www.arcussignum.sk
ETICS: Façade: ETICS with MW insulation, thicknesses of 50 mm – 200 mm (mostly 160 mm, bonded and mechanically fixed, reinforced base coat, silicate finishing coat.

Plinth area: ETICS with XPS insulation.

ETICS manufacturer: Baumit, www.baumit.sk
Member of: OZ ZPZ, www.zpzb.sk

EAE company member

Complementing
energy-efficiency
measures:
Roof insulation, insulation of dividing structures between heated and unheated spaces, replacement of the original fillings of the openings, replacement of the common distribution of sanitary equipment in the apartment building.
Financing measures: The renovation was financed from the State housing development fund SVK.